← Leaderboards
Alehandro Hoberman
University Of Pittsburgh At Pittsburgh
$9,526,532
Attributed
$9,526,532
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2010–16$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$9,526,532 · 1
By mechanism
N01$9,526,532 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Song Li$19,394,480
- Theresa L. Whiteside$29,550,469
- Lee H. Harrison$19,820,888
- Karen A Norris$27,323,771
- John F Alcorn$9,508,312
Others in their field
Top investigators on “Antibiotics”
- Laurence H Baker · University Of Michigan At Ann Arbor$52,071,546
- Clarence Buddy Creech · Vanderbilt University Medical Center$43,812,829
- Taha E Taha · Johns Hopkins University$37,363,329
- Urs Ochsner · Crestone, Inc.$36,950,837
- Deborah T Hung · Massachusetts General Hospital$36,871,538
- Ryan Cirz · Revagenix, Inc.$35,410,554
Research focus
AntibioticsAntimicrobial ResistanceProbabilityRegimenSafety TestingTherapeutic EffectivenessClinical TrialsDesignDrug ExposureDrug ResistanceChildhoodPneumoniaHaemophilus InfluenzaeMoraxella (Branhamella) Catarrhalis
Grant awards (17)
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance$617,199
N01 · FY2016 · AI · contact PI
Targeted Clinical Trials To Reduce the Risk of Antimicrobial Resistance$308,599
N01 · FY2016 · AI · contact PI
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance$308,593
N01 · FY2016 · AI · contact PI
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance$941,497
N01 · FY2015 · AI · contact PI
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance$471,501
N01 · FY2015 · AI · contact PI
Targeted Clinical Trials To Reduce the Risk of Antimicrobial Resistance$470,748
N01 · FY2015 · AI · contact PI
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance$1,007,468
N01 · FY2014 · AI · contact PI
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance$503,735
N01 · FY2014 · AI · contact PI
Targeted Clinical Trials To Reduce the Risk of Antimicrobial Resistance$503,734
N01 · FY2014 · AI · contact PI
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance$820,333
N01 · FY2013 · AI · contact PI
Targeted Clinical Trials To Reduce the Risk of Antimicrobial Resistance$410,665
N01 · FY2013 · AI · contact PI
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance$409,668
N01 · FY2013 · AI · contact PI
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance$901,465
N01 · FY2012 · AI · contact PI
Targeted Clinical Trials To Reduce the Risk of Antimicrobial Resistance$450,732
N01 · FY2012 · AI · contact PI
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance$450,732
N01 · FY2012 · AI · contact PI
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance$177,000
N01 · FY2011 · AI · contact PI
Targeted Clinical Trials to Reduce the Risk of Antimicrobial Resistance$772,863
N01 · FY2010 · AI · contact PI